4//SEC Filing
Coyne Terrance P. 4
Accession 0001802768-24-000051
CIK 0001802768other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:20 PM ET
Size
9.9 KB
Accession
0001802768-24-000051
Insider Transaction Report
Form 4
Coyne Terrance P.
EVP & CFO
Transactions
- Gift
ICAI Interests
2024-08-12−2,000→ 44,350 total(indirect: By LLC)→ LP interests in RPI US Partners 2019, LP (2,000 underlying)
Holdings
- 94,581(indirect: By LLC)
ICAI Interests
Exercise: $0.00→ LP interests in RPI US Partners 2019, LP (94,581 underlying) - 210,419(indirect: By LLC)
ICAI Interests
Exercise: $0.00→ LP interests in RPI US Partners 2019, LP (210,419 underlying)
Footnotes (3)
- [F1]No ICAI Interests or limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. ICAI Interests represent a grant of an equivalent number of limited partnership interest in RPI US LP ("RPI US LP Interest"). Each RPI US LP Interest may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with an exchange.
- [F2]The Reporting Person made a charitable donation of ICAI Interests. No Class A Ordinary Shares, RPI US LP Interests or ICAI Interests were sold.
- [F3]Represents ICAI Interests. Each ICAI Interests represents a grant of an equivalent number of RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001814876
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 7:20 PM ET
- Size
- 9.9 KB